Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.

Schimmel J, Eifler K, Sigurðsson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD, Francavilla C, Medema RH, Olsen JV, Vertegaal AC.

Mol Cell. 2014 Mar 20;53(6):1053-66. doi: 10.1016/j.molcel.2014.02.001. Epub 2014 Feb 27.

2.

SUMOylation inhibits FOXM1 activity and delays mitotic transition.

Myatt SS, Kongsema M, Man CW, Kelly DJ, Gomes AR, Khongkow P, Karunarathna U, Zona S, Langer JK, Dunsby CW, Coombes RC, French PM, Brosens JJ, Lam EW.

Oncogene. 2014 Aug 21;33(34):4316-29. doi: 10.1038/onc.2013.546. Epub 2013 Dec 23.

3.

SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.

Wang CM, Liu R, Wang L, Nascimento L, Brennan VC, Yang WH.

Int J Mol Sci. 2014 Jun 10;15(6):10233-51. doi: 10.3390/ijms150610233.

4.

Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase.

Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH.

Mol Cell Biol. 2005 Dec;25(24):10875-94.

5.

Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.

Fu Z, Malureanu L, Huang J, Wang W, Li H, van Deursen JM, Tindall DJ, Chen J.

Nat Cell Biol. 2008 Sep;10(9):1076-82. doi: 10.1038/ncb1767.

6.

C-terminus-deleted FoxM1 is expressed in cancer cell lines and induces chromosome instability.

Kim YH, Choi MH, Kim JH, Lim IK, Park TJ.

Carcinogenesis. 2013 Aug;34(8):1907-17. doi: 10.1093/carcin/bgt134. Epub 2013 Apr 24.

PMID:
23615399
7.

System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.

Xiao Z, Chang JG, Hendriks IA, Sigurðsson JO, Olsen JV, Vertegaal AC.

Mol Cell Proteomics. 2015 May;14(5):1419-34. doi: 10.1074/mcp.O114.044792. Epub 2015 Mar 9.

8.
9.

FoxM1 is required for execution of the mitotic programme and chromosome stability.

Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH.

Nat Cell Biol. 2005 Feb;7(2):126-36. Epub 2005 Jan 16.

PMID:
15654331
10.

Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.

Teh MT, Gemenetzidis E, Chaplin T, Young BD, Philpott MP.

Mol Cancer. 2010 Feb 26;9:45. doi: 10.1186/1476-4598-9-45.

11.

SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1.

Song JG, Xie HH, Li N, Wu K, Qiu JG, Shen DM, Huang CJ.

Tumour Biol. 2015 Dec;36(12):9865-71. doi: 10.1007/s13277-015-3737-z. Epub 2015 Jul 12. Retraction in: Tumour Biol. 2017 Apr 20;:.

PMID:
26164001
12.

Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.

Tan Y, Raychaudhuri P, Costa RH.

Mol Cell Biol. 2007 Feb;27(3):1007-16. Epub 2006 Nov 13.

13.

FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.

Petrovic V, Costa RH, Lau LF, Raychaudhuri P, Tyner AL.

J Biol Chem. 2008 Jan 4;283(1):453-60. Epub 2007 Nov 5.

14.

[Role of SUMO modification in the maintenance of genome stability].

Synowiec E, Ksiazek D, Błasiak J, Woźniak K.

Postepy Biochem. 2008;54(3):234-41. Review. Polish.

PMID:
19112822
15.

FoxM1, a forkhead transcription factor is a master cell cycle regulator for mouse mature T cells but not double positive thymocytes.

Xue L, Chiang L, He B, Zhao YY, Winoto A.

PLoS One. 2010 Feb 16;5(2):e9229. doi: 10.1371/journal.pone.0009229.

16.

Control of regional decidualization in implantation: Role of FoxM1 downstream of Hoxa10 and cyclin D3.

Gao F, Bian F, Ma X, Kalinichenko VV, Das SK.

Sci Rep. 2015 Sep 9;5:13863. doi: 10.1038/srep13863.

17.

The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.

Wang J, Qin H, Liang J, Zhu Y, Liang L, Zheng M, Han H.

J Mol Biol. 2007 Jun 29;370(1):27-38. Epub 2007 Apr 12.

PMID:
17509614
18.

Pax8 protein stability is controlled by sumoylation.

de Cristofaro T, Mascia A, Pappalardo A, D'Andrea B, Nitsch L, Zannini M.

J Mol Endocrinol. 2009 Jan;42(1):35-46. doi: 10.1677/JME-08-0100. Epub 2008 Oct 30.

PMID:
18974227
19.

An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.

Park HJ, Wang Z, Costa RH, Tyner A, Lau LF, Raychaudhuri P.

Oncogene. 2008 Mar 13;27(12):1696-704. Epub 2007 Sep 24.

20.

Cell cycle-dependent conjugation of endogenous BRCA1 protein with SUMO-2/3.

Vialter A, Vincent A, Demidem A, Morvan D, Stepien G, Venezia ND, Rio PG.

Biochim Biophys Acta. 2011 Apr;1810(4):432-8. doi: 10.1016/j.bbagen.2010.12.001. Epub 2010 Dec 13.

PMID:
21147198

Supplemental Content

Support Center